These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

460 related items for PubMed ID: 17989604

  • 21. Effect of metoprolol and ivabradine on left ventricular remodelling and Ca2+ handling in the post-infarction rat heart.
    Maczewski M, Mackiewicz U.
    Cardiovasc Res; 2008 Jul 01; 79(1):42-51. PubMed ID: 18310678
    [Abstract] [Full Text] [Related]

  • 22. Ivabradine: Current and Future Treatment of Heart Failure.
    Thorup L, Simonsen U, Grimm D, Hedegaard ER.
    Basic Clin Pharmacol Toxicol; 2017 Aug 01; 121(2):89-97. PubMed ID: 28371247
    [Abstract] [Full Text] [Related]

  • 23. Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice.
    Custodis F, Baumhäkel M, Schlimmer N, List F, Gensch C, Böhm M, Laufs U.
    Circulation; 2008 May 06; 117(18):2377-87. PubMed ID: 18443241
    [Abstract] [Full Text] [Related]

  • 24. Limited role for ivabradine in the treatment of chronic heart failure.
    Cullington D, Goode KM, Cleland JG, Clark AL.
    Heart; 2011 Dec 06; 97(23):1961-6. PubMed ID: 21917660
    [Abstract] [Full Text] [Related]

  • 25. Heart rate reduction by I(f)-channel inhibition and its potential role in heart failure with reduced and preserved ejection fraction.
    Reil JC, Reil GH, Böhm M.
    Trends Cardiovasc Med; 2009 Jul 06; 19(5):152-7. PubMed ID: 20005474
    [Abstract] [Full Text] [Related]

  • 26. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial.
    Ruzyllo W, Tendera M, Ford I, Fox KM.
    Drugs; 2007 Jul 06; 67(3):393-405. PubMed ID: 17335297
    [Abstract] [Full Text] [Related]

  • 27. Efficacy of ivabradine in combination with Beta-blocker versus uptitration of Beta-blocker in patients with stable angina.
    Amosova E, Andrejev E, Zaderey I, Rudenko U, Ceconi C, Ferrari R.
    Cardiovasc Drugs Ther; 2011 Dec 06; 25(6):531-7. PubMed ID: 21830063
    [Abstract] [Full Text] [Related]

  • 28. Cardioprotective effects of the Ιf current inhibition by ivabradine during cardiac dysfunction.
    Su JB.
    Curr Pharm Biotechnol; 2014 Dec 06; 14(14):1213-9. PubMed ID: 24831809
    [Abstract] [Full Text] [Related]

  • 29. Ivabradine as an alternative therapeutic trial in the therapy of inappropriate sinus tachycardia: a case report.
    Schulze V, Steiner S, Hennersdorf M, Strauer BE.
    Cardiology; 2008 Dec 06; 110(3):206-8. PubMed ID: 18057886
    [Abstract] [Full Text] [Related]

  • 30. Pharmacokinetic-pharmacodynamic modeling of the effects of ivabradine, a direct sinus node inhibitor, on heart rate in healthy volunteers.
    Ragueneau I, Laveille C, Jochemsen R, Resplandy G, Funck-Brentano C, Jaillon P.
    Clin Pharmacol Ther; 1998 Aug 06; 64(2):192-203. PubMed ID: 9728900
    [Abstract] [Full Text] [Related]

  • 31. Cardiogenic shock due to tachycardiomyopathy after heart transplantation: successful treatment with ivabradine.
    Zwicker C, Becker M, Lepper W, Koch KC, Westenfeld R.
    Cardiology; 2010 Aug 06; 116(3):174-7. PubMed ID: 20628253
    [Abstract] [Full Text] [Related]

  • 32. Ivabradine treatment prevents dobutamine-induced increase in heart rate in patients with acute decompensated heart failure.
    Cavusoglu Y, Mert U, Nadir A, Mutlu F, Morrad B, Ulus T.
    J Cardiovasc Med (Hagerstown); 2015 Sep 06; 16(9):603-9. PubMed ID: 24922198
    [Abstract] [Full Text] [Related]

  • 33. Effects of heart rate reduction with ivabradine on exercise-induced myocardial ischemia and stunning.
    Monnet X, Ghaleh B, Colin P, de Curzon OP, Giudicelli JF, Berdeaux A.
    J Pharmacol Exp Ther; 2001 Dec 06; 299(3):1133-9. PubMed ID: 11714904
    [Abstract] [Full Text] [Related]

  • 34. Heart rate reduction by inhibition of If or by beta-blockade has different effects on postsystolic wall thickening.
    Lucats L, Ghaleh B, Colin P, Monnet X, Bizé A, Berdeaux A.
    Br J Pharmacol; 2007 Feb 06; 150(3):335-41. PubMed ID: 17179940
    [Abstract] [Full Text] [Related]

  • 35. Safety of ivabradine in patients with coronary artery disease and left ventricular systolic dysfunction (from the BEAUTIFUL Holter Substudy).
    Tendera M, Talajic M, Robertson M, Tardif JC, Ferrari R, Ford I, Steg PG, Fox K, BEAUTIFUL Investigators.
    Am J Cardiol; 2011 Mar 15; 107(6):805-11. PubMed ID: 21247517
    [Abstract] [Full Text] [Related]

  • 36. Effects of ivabradine in patients with stable angina receiving β-blockers according to baseline heart rate: an analysis of the ASSOCIATE study.
    Tardif JC, Ponikowski P, Kahan T, ASSOCIATE Investigators.
    Int J Cardiol; 2013 Sep 30; 168(2):789-94. PubMed ID: 23138014
    [Abstract] [Full Text] [Related]

  • 37. Exercise tolerance after beta blockade in recent cardiac transplant recipients.
    Buendía Fuentes F, Almenar Bonet L, Martínez-Dolz L, Sancho-Tello de Carranza MJ, Moro López J, Agüero Ramón-Llin J, Sánchez-Lázaro I, Sánchez-Gómez JM, Raso Raso R, Navarro Manchón J, Salvador Sanz A.
    Transplant Proc; 2009 Sep 30; 41(6):2250-2. PubMed ID: 19715889
    [Abstract] [Full Text] [Related]

  • 38. Focus on ivabradine: a new heart rate-controlling drug.
    Riccioni G.
    Expert Rev Cardiovasc Ther; 2009 Feb 30; 7(2):107-13. PubMed ID: 19210206
    [Abstract] [Full Text] [Related]

  • 39. Influence of background treatment with mineralocorticoid receptor antagonists on ivabradine's effects in patients with chronic heart failure.
    Komajda M, Böhm M, Borer J, Ford I, Krum H, Tase A, Tavazzi L, Swedberg K.
    Eur J Heart Fail; 2013 Jan 30; 15(1):79-84. PubMed ID: 22892123
    [Abstract] [Full Text] [Related]

  • 40. Long-term safety and efficacy of ivabradine in patients with chronic stable angina.
    López-Bescós L, Filipova S, Martos R.
    Cardiology; 2007 Jan 30; 108(4):387-96. PubMed ID: 17890862
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.